Fukushima, Tatsuo
Tsujino, Takuya
Sakamoto, Moritoshi
Takahara, Kiyoshi
Komura, Kazumasa
Yanagisawa, Takafumi
Mori, Keiichiro
Fukuokaya, Wataru
Urabe, Fumihiko
Adachi, Takahiro
Hirasawa, Yosuke
Saruta, Masanobu
Yoshizawa, Atsuhiko
Toyoda, Shingo
Kawada, Tatsushi
Katayama, Satoshi
Iwatsuki, Kengo
Nakamura, Ko
Nishio, Kyosuke
Nishimura, Kazuki
Nakamori, Keita
Matsunaga, Tomohisa
Maenosono, Ryoichi
Uchimoto, Taizo
Takai, Tomoaki
Hashimoto, Takeshi
Inamoto, Teruo
Fujita, Kazutoshi
Araki, Motoo
Kimura, Takahiro
Ohno, Yoshio
Shiroki, Ryoichi
Azuma, Haruhito
Funding for this research was provided by:
Japan Society for the Promotion of Science (23K14606)
Nippon Shinyaku
Uehara Memorial Foundation
Article History
Received: 30 December 2024
Accepted: 9 February 2025
First Online: 24 February 2025
Declarations
:
: This study was approved by the Institutional Review Board (IRB) from Osaka Medical and Pharmaceutical University (approval number: RIN-750-2571, approved on 24th January 2020). This observational study adhered to ethical principles aligned with the Declaration of Helsinki, the International Conference on Harmonization’s Good Clinical Practice guidelines, Good Pharmacoepidemiology Practices, and relevant laws for noninterventional and observational studies.
: The authors declare no competing interests.